LETM2
LETM1 domain-containing protein LETM2, mitochondrial
Also known as: FLJ25409, LETM2_HUMAN, SLC55A2
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q2VYF4
- Gene
- LETM2
- Ensembl
- ENSG00000165046
- Chromosome
- 8
- Canonical length
- 491 aa
- Protein class
- Predicted intracellular proteins, Predicted membrane proteins, Transporters
- Subcellular location
- Nucleoplasm,Nuclear bodies,Cytosol
OverviewNCBI Gene
Predicted to enable transmembrane transporter activity. Predicted to be involved in mitochondrial calcium ion transmembrane transport and mitochondrion organization. Located in mitochondrion. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
491 residues, UniProt reviewed canonical sequence.
>Q2VYF4|LETM2
1 MAFYSYNSVL AIARTRFPSH FVHPTCSSYS PSCAFLHLPD SHLNKTCMKN YESKKYSDPS
61 QPGNTVLHPG TRLIQKLHTS TCWLQEVPGK PQLEQATKHP QVTSPQATKE TGMEIKEGKQ
121 SYRQKIMDEL KYYYNGFYLL WIDAKVAARM VWRLLHGQVL TRRERRRLLR TCVDFFRLVP
181 FMVFLIVPFM EFLLPVFLKL FPEMLPSTFE SESKKEEKQK KKMAVKLELA KFLQETMTEM
241 ARRNRAKMGD ASTQLSSYVK QVQTGHKPST KEIVRFSKLF EDQLALEHLD RPQLVALCKL
301 LELQTFGTNN LLRFQLLMKL KSIKADDEII AKEGVTALSV SELQAACRAR GMRSLGLTEE
361 QLRQQLTEWQ DLHLKENVPP SLLLLSRTFY LIDVKPKPIE IPLSGEAPKT DILVELPTFT
421 ESKENMVDLA PQLKGTKDED FIQPPPVTSS PITPSTPISL PKGPITSSEE PTLQAKSQMT
481 AQNSKASSKG ALocalizationUniProt · AlphaFold · HPA
Whether an antibody against LETM2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.5
- Highest tissue expression
- 22 nTPM
Expression across tissuesHPA
Tissue
- testis: 22 nTPM
- choroid plexus: 14 nTPM
- bone marrow: 5 nTPM
- retina: 3.9 nTPM
- cerebellum: 3.8 nTPM
- cerebral cortex: 2.6 nTPM
Single-cell type
- epicardial cells: 175 nCPM
- late primary spermatocytes: 132 nCPM
- late spermatids: 75 nCPM
- early spermatids: 50 nCPM
- endometrial luminal cells: 42 nCPM
- endometrial ciliated cells: 40 nCPM
Immune cell
- neutrophil: 22 nTPM
- non-classical monocyte: 5.2 nTPM
- T-reg: 5.2 nTPM
- classical monocyte: 4.1 nTPM
- MAIT T-cell: 2 nTPM
- naive B-cell: 1.8 nTPM
Brain region
- cerebellum: 16 nTPM
- white matter: 13 nTPM
- cerebral cortex: 12 nTPM
- basal ganglia: 12 nTPM
- pons: 11 nTPM
- midbrain: 11 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.54
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.06
- DepMap mean gene effect
- -0.01
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- LETM1-like, ribosome-binding domain
- LETM1/MDM38-like
- LETM1-like, RBD
- LETM2, N-terminal
- LETM1 domain-containing protein LETM2 N-terminus
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads LETM2 as an antibody target. Whether an autoantibody or antibody against LETM2 could matter depends on whether native LETM2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
LETM2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label LETM2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...